| 000 | 01119 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515081413.0 | ||
| 264 | 0 | _c20080104 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a0902-4506 | ||
| 024 | 7 |
_a10.1111/j.1600-0609.2007.00943.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGriesshammer, Martin | |
| 245 | 0 | 0 |
_aOptions in the management of essential thrombocythaemia. _h[electronic resource] |
| 260 |
_bEuropean journal of haematology. Supplementum _cOct 2007 |
||
| 300 |
_a35-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxyurea _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aQuinazolines _xtherapeutic use |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombocythemia, Essential _xdrug therapy |
| 773 | 0 |
_tEuropean journal of haematology. Supplementum _gno. 68 _gp. 35-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1600-0609.2007.00943.x _zAvailable from publisher's website |
| 999 |
_c17257376 _d17257376 |
||